✦ LIBER ✦

Nexopamil (LU 49938), A Combined Ca2+Channel Blocker and 5HT2Receptor Antagonist

✍ Scribed by Kirchengast, Michael

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overlap in the Pharmacology of L-type Ca

✍ E. O. Okoro 📂 Article 📅 1999 🏛 Pharmaceutical Press 🌐 English ⚖ 70 KB

The Ca2+ channel and 5-HT2 receptor anta

✍ F.V. Defeudis 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Ischemia-induced impairment of 2-deoxygl

✍ Shigenobu Shibata; Yoshifumi Kagami-Ishi; Keiko Tominaga; Koutaroh Kodama; Showa 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 952 KB

Evidence for accelerated desensitisation

✍ L.J Bristow; D O'Connor; R Watts; M.S Duxon; P.H Hutson 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 499 KB

Combined administration of an mGlu2/3 re

✍ Jason M. Uslaner; Sean M. Smith; Sarah L. Huszar; Rashida Pachmerhiwala; Richard 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 326 KB

Comparison of the effects of apamin, a C

✍ Jeffrey S. Fedan; G.Kurt Hogaboom; John P. O'Donnell 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 574 KB